The bill removes an outdated ONDCP statutory provision to reduce administrative burden and compliance costs, but it risks creating legal gaps, reducing program protections, and weakening oversight until replacements or clarifications are put in place.
Federal agencies (including ONDCP) will have fewer administrative constraints and simpler internal duties, making day-to-day operations easier for agency staff and reducing administrative burden.
Nonprofits and government contractors that work with ONDCP may face reduced legal complexity and lower compliance costs because an obsolete or duplicative statutory requirement is removed.
Nonprofits and some federal programs could lose statutory authority, coordination, or protections previously provided by the deleted subsection, which may reduce services or support for program beneficiaries.
Federal employees, contractors, and the programs they run could face legal ambiguity about roles and responsibilities until Congress or the agency issues a replacement or guidance, potentially disrupting services or contracts.
Taxpayers and nonprofits could see weakened oversight or fewer safeguards if the repeal removed prohibitions or limits, increasing the risk of expanded agency discretion or improper actions.
Based on analysis of 2 sections of legislative text.
Removes 21 U.S.C. 1703(b)(12), deleting that specific statutory subsection from the ONDCP statute.
Official title: To repeal section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998, and for other purposes.
Introduced April 29, 2025 by Alice Costandina Titus · Last progress April 29, 2025
Repeals a single statutory subsection of the Office of National Drug Control Policy’s enabling statute by removing 21 U.S.C. 1703(b)(12). The change deletes whatever appointment, duty, prohibition, or coordinator provision had been set out in that numbered subsection and does not create new funding, new programs, or additional duties.